Bridgebio Pharma Inc Earnings

Bridgebio Pharma Inc’s revenue fell -44.76% since last year same period to $116.63Mn in the Q1 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 1882.88% jump in its revenue since last 3-months.

Bridgebio Pharma Inc’s net profit fell -375.41% since last year same period to $-167.42Mn in the Q1 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 36.83% jump in its net profits since last 3-months.

Bridgebio Pharma Inc’s net profit margin fell -760.56% since last year same period to -143.55% in the Q1 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 96.81% jump in its net profit margins since last 3-months.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a -4.92% fall from last quarter’s estimates.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.78.

Bridgebio Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Bridgebio Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.